Johnson & Johnson and Sanofi's vaccine for preventing invasive disease caused by the problem pathogen Escherichia coli looks all but defunct after the two partners halted a phase 3 trial. In a ...

This database originally covered cases from 1982 to 2012 and has since been updated and expanded numerous times. For analysis and context on this data—including how we built the database, and a change ...